Patents by Inventor Martin P. STEINBUCK

Martin P. STEINBUCK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250249107
    Abstract: The invention provides compounds including a KRAS sequence that is linked to a lipid by a linker, and related compositions and methods.
    Type: Application
    Filed: April 23, 2025
    Publication date: August 7, 2025
    Inventors: Peter C. DEMUTH, Julian ADAMS, Martin P. STEINBUCK
  • Publication number: 20250134992
    Abstract: Disclosed herein are polyadenosine, polythymidine, polyguanosine, and/or polycytosine nucleic acid sequences, as well as interferon stimulatory DNA and immunostimulatory herpes simplex virus sequences, that may be conjugated to an albumin-binding domain, as well as pharmaceutically acceptable salts thereof. Furthermore, disclosed herein are methods for inducing an immune response in a subject, and methods of administering the polyadenosine, polythymidine, polyguanosine, and/or polycytosine nucleic acid sequences conjugated to an albumin-binding domain and an antigen to induce an immune response in a subject.
    Type: Application
    Filed: August 15, 2022
    Publication date: May 1, 2025
    Inventors: Peter C. DEMUTH, Martin P. STEINBUCK
  • Publication number: 20250009888
    Abstract: The invention provides compounds including a KRAS sequence that is linked to a lipid by a linker, and related compositions and methods.
    Type: Application
    Filed: September 11, 2024
    Publication date: January 9, 2025
    Inventors: Peter C. DEMUTH, Julian ADAMS, Martin P. STEINBUCK
  • Publication number: 20230263882
    Abstract: Disclosed herein are CpG-amphiphiles and corona virus antigens (e.g., a coronavirus spike protein, a peptide thereof, or a nucleic acid sequence encoding the same) for use in inducing an immune response in a subject, and methods of administering CpG-amphiphiles and coronavirus antigens (e.g., a coronavirus spike protein, a peptide thereof, a coronavirus nucleocapsid protein, a peptide thereof, or a nucleic acid sequence encoding the same) to induce an immune response in a subject.
    Type: Application
    Filed: June 25, 2021
    Publication date: August 24, 2023
    Inventors: Martin P. STEINBUCK, Lochana M. SEENAPPA, Peter C. DEMUTH, Christopher M. HAQQ, Lisa MCNEIL